{"nct_id":"NCT02553317","title":"Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura","status":"COMPLETED","status_verified_date":"2019-05","start_date":"2015-11","start_date_type":"ACTUAL","primary_completion_date":"2017-08","primary_completion_date_type":"ACTUAL","completion_date":"2017-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}